119 related articles for article (PubMed ID: 21222614)
1. Synthesis and antiviral evaluation of bisnoradamantane sulfites and related compounds.
Valverde E; Torres E; Guardiola S; Naesens L; Vázquez S
Med Chem; 2011 Mar; 7(2):135-9. PubMed ID: 21222614
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antifungal, antibacterial and antiviral effects of some adamantaneketoxime ethers.
Papadaki-Valiraki A; Papakonstantinou-Garoufalias S; Marakos P; Chytyroglou-Lada A; Hosoya M; Balzarini J; de Clercq E
Farmaco; 1993 Aug; 48(8):1091-102. PubMed ID: 8216671
[TBL] [Abstract][Full Text] [Related]
3. Substituted adamantylphthalimides: Synthesis, antiviral and antiproliferative activity.
Mandić L; Benčić P; Mlinarić-Majerski K; Liekens S; Snoeck R; Andrei G; Kralj M; Basarić N
Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000024. PubMed ID: 32285536
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.
Kolocouris N; Kolocouris A; Foscolos GB; Fytas G; Neyts J; Padalko E; Balzarini J; Snoeck R; Andrei G; De Clercq E
J Med Chem; 1996 Aug; 39(17):3307-18. PubMed ID: 8765514
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles.
Kritsanida M; Mouroutsou A; Marakos P; Pouli N; Papakonstantinou-Garoufalias S; Pannecouque C; Witvrouw M; De Clercq E
Farmaco; 2002 Mar; 57(3):253-7. PubMed ID: 11989804
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
Zarubaev VV; Golod EL; Anfimov PM; Shtro AA; Saraev VV; Gavrilov AS; Logvinov AV; Kiselev OI
Bioorg Med Chem; 2010 Jan; 18(2):839-48. PubMed ID: 20006516
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
Zoidis G; Kolocouris N; Naesens L; De Clercq E
Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and antiviral activity of three libraries of adamantane derivatives.
Basarić N; Sohora M; Cindro N; Mlinarić-Majerski K; De Clercq E; Balzarini J
Arch Pharm (Weinheim); 2014 May; 347(5):334-40. PubMed ID: 24532384
[TBL] [Abstract][Full Text] [Related]
9. Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity.
Shiryaev VA; Skomorohov MY; Leonova MV; Bormotov NI; Serova OA; Shishkina LN; Agafonov AP; Maksyutov RA; Klimochkin YN
Eur J Med Chem; 2021 Oct; 221():113485. PubMed ID: 33965861
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, conformational characteristics and anti-influenza virus A activity of some 2-adamantylsubstituted azacycles.
Setaki D; Tataridis D; Stamatiou G; Kolocouris A; Foscolos GB; Fytas G; Kolocouris N; Padalko E; Neyts J; De Clercq E
Bioorg Chem; 2006 Oct; 34(5):248-73. PubMed ID: 16879857
[TBL] [Abstract][Full Text] [Related]
11. Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantane.
Vasilenko DA; Dueva EV; Kozlovskaya LI; Zefirov NA; Grishin YK; Butov GM; Palyulin VA; Kuznetsova TS; Karganova GG; Zefirova ON; Osolodkin DI; Averina EB
Bioorg Chem; 2019 Jun; 87():629-637. PubMed ID: 30947098
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.
Duque MD; Camps P; Profire L; Montaner S; Vázquez S; Sureda FX; Mallol J; López-Querol M; Naesens L; De Clercq E; Prathalingam SR; Kelly JM
Bioorg Med Chem; 2009 Apr; 17(8):3198-206. PubMed ID: 19251424
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of bioactive adamantane spiro heterocycles.
Kolocouris N; Zoidis G; Foscolos GB; Fytas G; Prathalingham SR; Kelly JM; Naesens L; De Clercq E
Bioorg Med Chem Lett; 2007 Aug; 17(15):4358-62. PubMed ID: 17588747
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activity evaluation of some aminoadamantane derivatives.
Kolocouris N; Foscolos GB; Kolocouris A; Marakos P; Pouli N; Fytas G; Ikeda S; De Clercq E
J Med Chem; 1994 Sep; 37(18):2896-902. PubMed ID: 8071937
[TBL] [Abstract][Full Text] [Related]
15. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains.
Kuznetsov NY; Tikhov RM; Godovikov IA; Medvedev MG; Lyssenko KA; Burtseva EI; Kirillova ES; Bubnov YN
Org Biomol Chem; 2017 Apr; 15(15):3152-3157. PubMed ID: 28338150
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of derivatives of N-(1-adamantyl)-N'-urea with potential antiviral activity].
Skwarski D; Maliszewska H
Acta Pol Pharm; 1988; 45(5):391-4. PubMed ID: 3247849
[No Abstract] [Full Text] [Related]
18. Synthesis, X-ray crystal structure study, and cytostatic and antiviral evaluation of the novel cycloalkyl-N-aryl-hydroxamic acids.
Barbarić M; Ursić S; Pilepić V; Zorc B; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; Snoeck R; Andrei G; Balzarini J; De Clercq E; Mintas M
J Med Chem; 2005 Feb; 48(3):884-7. PubMed ID: 15689173
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of aminoadamantane derivatives for in vitro anti-HIV and antitumor activities.
da Settimo A; Marini AM; Primofiore G; Da Settimo F
Farmaco; 1995 May; 50(5):321-6. PubMed ID: 7626166
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.
Zoidis G; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Eur J Med Chem; 2010 Nov; 45(11):5022-30. PubMed ID: 20805012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
